Beskrivning
Thrombopoietin (TPO) is a key regulator of megakaryocytopoiesis and thrombopoiesis. The human TPO precursor consists of 353 amino acids and is cleaved to yield a 332-amino-acid mature protein. Mature human TPO shares approximately 70% amino acid sequence homology with mouse and rat TPO. TPO and its receptor (c-Mpl) are the primary regulators of megakaryocyte and platelet production, playing a critical and indispensable role in hematopoietic stem cell (HSC) biology. TPO exerts its effects through the Jak-STAT, Ras-Raf-MAPK, and PI3K signaling pathways, promoting the survival, proliferation, and polyploidization of megakaryocytes. TPO is a megakaryocyte lineage-specific growth factor. In in vitro culture systems, the addition of recombinant human TPO can induce the differentiation of CD34+ hematopoietic stem cells into megakaryocytes and promote the maturation of polyploid megakaryocytes and platelet release. TPO protein can be used to study the regulation of megakaryocyte development, the molecular mechanisms of thrombopoiesis, and to screen for platelet-promoting drugs. TPO is commonly used in combination with cytokines such as SCF and FLT3-L for the in vitro expansion of hematopoietic stem cells and progenitor cells.
Product Information
|
Product Name |
Catalog No. |
Size |
|
Recombinant Human Thrombopoietin GMP Protein |
92363ES10 |
10 μg |
|
92363ES50 |
50 μg |
|
|
92363ES80 |
1 mg (20 × 50 μg) |
Specifications
|
Synonyms |
MGDF, MGDFC-mpl ligand, MKCSF, MK-CSF, ML, MPL ligand, MPLLG, THCYT1, THPO |
|
Species |
Human |
|
Expression Sequence |
Ser 22-Gly 353 |
|
Accession |
P40225-1 |
|
Tag |
No Tag |
|
Expression System |
CHO |
|
Molecular Weight |
The protein has a calculated MW of 35.5 kDa. The protein migrates as 75 to 95 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation. |
|
Purity |
> 95% as determined by SDS-PAGE. |
|
Endotoxin |
< 0.01 EU/ug protein as determined by LAL method. |
|
Formulation |
Lyophilized from 0.22 um filtered solution in PBS, pH 7.4 with trehalose as protectant. |
|
Appearance |
Lyophilized Powder |
|
Biological Activity |
ED50 < 10 ng/mL, measured in a cell proliferation assay using Human M07e cells. |
|
Reconstitution Method |
It is recommended to reconstitute the protein in sterile PBS (pH 7.4) to a concentration of 0.1-1.0 mg/mL. Avoid repeated freeze-thaw cycles whenever possible. |
Feature
- High Purity: > 95%, avoiding immune reactions caused by host protein (HCP) or DNA residue.
- Ultra-low Endotoxin: < 10 EU/mg, reducing the risk of fever or inflammation.
- Batch-to-Batch Consistency: Ensuring stability and reproducibility in cell culture.
- Regulatory Compliance: Meeting regulatory requirements for cell therapy products, supporting IND filing.
- Animal-free: Free from animal viruses, pathogenic substances, and exogenous factor contamination, with high safety.
Regulatory Compliance Guidelines
The production and quality control of GMP-grade proteins comply with the following systems and procedures:
1. Complies with the General Requirements of Part III of the Pharmacopoeia of the People's Republic of China (2020 Edition): Quality Control of Raw Materials and Excipients for Biological Products.
2. Complies with USP Chapter <92> Growth Factors and Cytokines Used in Cell Therapy Manufacturing.
3. Complies with Ph. Eur. General Chapter 5.2.12, Raw Materials of Biological Origin for the Production of Cell-based and Gene Therapy Medicinal Products.
Quality Management System
1. GMP proteins are produced, tested, and released under a quality management system certified to ISO 13485:2016, ensuring batch-to-batch consistency and material traceability.
2. Certificate of Analysis (COA) provided.
3. Animal-free materials and production environment.
4. Pharmaceutical product raw and auxiliary material production facility.
5. Online/offline audit supported.
Product Safety Quality Control System
Endotoxin: < 10 EU/mg
Residual Host DNA: < 20 ng/mg
Residual Host Protein: < 0.5 ng/ug
Sterility Test: Negative
Mycoplasma Test: Negative
Exogenous Virus Test: Negative
Figure
SDS-PAGE
Figure 1: The purity is greater than 95% as determined by SDS-PAGE under reduced condition.
Bioactivity
Figure 2: The ED50 as determined by a cell proliferation assay using human M07e cells is less than 10 ng/mL.
Storage
Store at -25 to -15°C for 3 years. After reconstitution, store at -85 to -65°C for 3 months.
Documents:
Safety Data Sheet
Manuals:
Betalning och säkerhet
Din betalningsinformation behandlas säkert. Vi lagrar inte kreditkortsuppgifter och har inte heller tillgång till din kreditkortsinformation.
Du kanske också gillar
Förfrågan
Vanliga frågor
Produkten är endast avsedd för forskningsändamål och är inte avsedd för terapeutisk eller diagnostisk användning hos människor eller djur. Produkter och innehåll skyddas av patent, varumärken och upphovsrätt som ägs av Yeasen Biotechnology. Varumärkessymboler anger ursprungsland, inte nödvändigtvis registrering i alla regioner.
Vissa applikationer kan kräva ytterligare immateriella rättigheter från tredje part.
Yeasen är dedikerad till etisk vetenskap, och anser att vår forskning bör behandla kritiska frågor samtidigt som den säkerställer säkerhet och etiska standarder.